Praxis Precision Medicines (PRAX) Total Current Liabilities (2019 - 2026)

Praxis Precision Medicines' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $50.2 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 27.12% year-over-year to $50.2 million in Q1 2026; TTM through Mar 2026 was $50.2 million, a 27.12% increase from a year earlier, with the FY2025 full-year figure at $59.8 million, up 59.18% from the prior year.
• Total Current Liabilities fell to $50.2 million in Q1 2026 per PRAX's latest filing, from $59.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $59.8 million in Q4 2025 and bottomed at $15.7 million in Q4 2023.
• The 5-year median for Total Current Liabilities is $34.3 million (2022), against an average of $35.0 million.
• Across the five-year window, Total Current Liabilities soared 229.18% in 2022 and slumped 54.14% in 2023, its largest moves.
• Year by year, Total Current Liabilities stood at $34.3 million in 2022, then slumped by 54.14% to $15.7 million in 2023, then surged by 138.43% to $37.6 million in 2024, then surged by 59.18% to $59.8 million in 2025, then slipped by 15.94% to $50.2 million in 2026.
• Per Business Quant, the three latest PRAX Total Current Liabilities figures stand at $50.2 million (Q1 2026), $59.8 million (Q4 2025), and $52.9 million (Q3 2025).